U.S. Entertainment Stock News

Wave Life Sciences (WVE) drew investor attention after reporting first quarter 2026 results, with sales of US$38.25 million, a net loss of US$26.09 million, and progress across several RNA based clinical programs. See our latest analysis for Wave Life Sciences. Despite the earnings beat and clinical updates, the recent 7.17% 1 month share price return to US$7.32 comes after a much steeper 43.43% 3 month share price decline. The 3 year total shareholder return of 83.46% contrasts with a 9.63%...

Dolby Laboratories (DLB) has put up a solid Q2 2026 scorecard, with revenue of US$395.6 million and basic EPS of US$1.00, setting a clear marker for how the year is shaping up. Over the past few quarters the company has seen revenue move from US$356.999 million in Q1 2025 to US$369.561 million in Q2 2025, then to US$346.706 million in Q1 2026 and now US$395.63 million, while basic EPS tracked from US$0.71 to US$0.95, then US$0.56 and now just under US$1.00. With a trailing twelve month net...

For investors considering whether H.B. Fuller is currently priced attractively or if the recent share price leaves limited potential upside, this article focuses on what the current valuation suggests. The stock last closed at US$59.95, with a 12.1% return over the past year. However, recent 7-day and 30-day returns of 4.6% and 4.0% declines, along with a small 0.6% decline year to date, indicate that sentiment has been more cautious lately. Recent coverage has centered on how H.B. Fuller is...

In recent days, Ovintiv has attracted growing attention as analysts broadly raised their earnings estimates for the next quarter and full year, while major institutional holders such as Vanguard disclosed multi-million-share, passive stakes in the company. This combination of upgraded earnings expectations, continued bullish analyst views, and concentrated institutional ownership has sharpened the focus on how Ovintiv’s fundamentals align with differing assessments of its intrinsic value and...

Builders FirstSource (BLDR) just posted Q1 2026 results with revenue of US$3.3b and a net loss of US$47.4m, translating to a basic EPS loss of US$0.43 as investors reassess how earnings power is tracking into the new year. The company has seen quarterly revenue move from US$3.7b and EPS of US$0.85 in Q1 2025 to US$3.3b and a loss per share in the latest quarter, which puts the spotlight firmly on how quickly profitability can be rebuilt from here. With trailing profit margins thinner than a...

If you are wondering whether PepsiCo's current share price offers fair value or a margin of safety, the numbers behind the stock can help frame that decision. At a last close of US$157.41, PepsiCo has recorded returns of 1.3% over 7 days, 1.8% over 30 days, 10.7% year to date, 22.4% over 1 year, negative 10.3% over 3 years and 26.3% over 5 years. This gives you several different entry points to think about. Recent coverage has focused on PepsiCo's role as a global beverages and snacks...

Wondering whether Preformed Line Products at around US$333 per share still offers value, or if the best of the opportunity is already behind it? This breakdown is designed to help you make sense of the current price. The stock has been volatile recently, with a 5.0% decline over the last 7 days, a 14.5% gain across the past month, a 57.5% return year to date, and a 143.9% return over the last 12 months. These moves have put the company back on many investors' radars, especially as they...

Wondering whether LSB Industries at US$14.77 still offers value after a strong run? This article focuses squarely on what the current price might mean for you. The stock has returned 2.6% over the last 7 days, is down 1.1% over 30 days, and shows YTD returns of 72.3% and 123.8% over 1 year that may signal changing views on its potential and risk. Recent coverage has focused on LSB Industries' share price performance and how investors are reacting to company updates. This helps explain some...

Stryker (SYK) opened 2026 with Q1 revenue of US$6.0b and basic EPS of US$1.95, while trailing twelve month figures stood at US$25.3b in revenue and basic EPS of US$8.72, giving investors a clear read on the latest run rate. The company has seen quarterly revenue move from US$5.9b in Q1 2025 to US$6.0b in Q1 2026, with basic EPS over that period shifting from US$1.71 to US$1.95, and those results sit against a backdrop of earnings growth that has outpaced revenue and supported firmer net...

Macerich (MAC) has drawn fresh attention after recent share performance, with the stock showing gains over the past month and past 3 months. This has prompted investors to reassess its valuation and income profile. See our latest analysis for Macerich. The recent 10.94% 1 month share price return and 16.09% year to date share price return, alongside a 47.03% 1 year total shareholder return and very large 3 year total shareholder return, point to momentum that buyers are still willing to test...

Air Products and Chemicals (APD) has put down another solid quarter, with Q2 2026 revenue of US$3.2 billion and basic EPS of US$3.19, supported by net income of US$710.4 million. The company has seen quarterly revenue move from US$2,916.2 million in Q2 2025 to US$3,171.8 million in Q2 2026, while basic EPS shifted from a loss of US$7.77 per share in Q2 2025 to a profit of US$3.19. This sets up the latest release as a clean read on current profitability. With trailing net margins running at...

International Paper (IP) opened 2026 with Q1 revenue of US$6.0 billion and basic EPS of US$0.14, setting a more stable starting point after a volatile run of quarterly results. Over recent periods, the company has seen revenue move from US$3.9 billion in Q4 2024 to just over US$6.0 billion in Q4 2025. Basic EPS has swung from a profit of US$0.25 in Q4 2024 to a loss of US$4.48 in Q4 2025 and then back to a modest profit in Q1 2026, keeping investor attention firmly on the direction of margins...

If you are wondering whether KLA's current share price still offers value, you are not alone; many investors are asking the same question after such a strong run. The stock closed at US$1,726.26, with a 149.1% return over the last year, 35.4% year to date, 13.6% over the past 30 days, and a 10.8% decline over the past week, so recent moves have been far from quiet. Over the past few months, KLA has been in the spotlight as part of broader interest in semiconductor names, with attention on...

American Assets Trust (AAT) is in focus after releasing first quarter 2026 results, reporting higher sales and revenue along with significantly lower net income and earnings per share, and reaffirming its regular cash dividend. See our latest analysis for American Assets Trust. The earnings release and confirmed dividend arrived after a strong run, with a 30 day share price return of 13.24% and a 1 year total shareholder return of 16.41%. Meanwhile, the 5 year total shareholder return of a...

Emergent BioSolutions (EBS) opened 2026 with Q1 revenue of US$156.1 million and basic EPS of US$0.13, alongside trailing 12 month revenue of US$676.8 million and a TTM basic EPS loss of US$0.16. This gives investors a fresh look at how current margins compare with a still unprofitable recent track record. Over the past few quarters, the company has seen quarterly revenue move between US$140.9 million and US$231.1 million, with basic EPS swinging from a loss of US$1.04 in Q4 2025 to a profit...

Tetra Tech (TTEK) is on investors’ radar after recent share price moves, with the stock closing at US$31.67 and showing mixed short term returns over the past week, month and past 3 months. See our latest analysis for Tetra Tech. Looking beyond the latest move, the 30 day share price return of 3.06% sits against a 90 day share price decline of 15.91%. The 1 year total shareholder return of 2.96% and 5 year total shareholder return of 31.82% point to steadier long term compounding. If you are...

If you are wondering whether Elastic at US$48.61 is a bargain or just looks cheap, it helps to line up the numbers behind the share price first. The stock has seen a mixed run recently, with a 4.8% gain over the last 7 days, a 2.6% decline over 30 days, and returns of 33.0% decline year to date and 41.4% decline over 1 year that may have changed how the market prices its risk and potential. Over the past few years, investors have also had to weigh multi year returns of 14.2% decline over 3...

In April 2026, Nasdaq, Inc. reported higher first-quarter revenue of US$1,407 million and net income of US$519 million year-on-year, declared a regular quarterly dividend of US$0.31 per share payable on June 26, 2026, and completed a long-running share repurchase program totaling 48,547,848 shares for US$4.61 billions. The quarter also underlined the rising importance of Nasdaq’s Financial Technology division, with management highlighting cloud- and AI-driven solutions, upcoming 23/5...

Adeia (ADEA) is back on investors’ radar after S&P Global Ratings raised the company’s issuer credit rating from BB minus to BB with a stable outlook, highlighting progress on financial priorities. See our latest analysis for Adeia. The S&P upgrade and fresh disclosures showing Vanguard holding more than 5% of Adeia’s shares have coincided with strong momentum, with a 30 day share price return of 31.63% and a one year total shareholder return of 165.26%. If this kind of rerating catches your...

Hershey (NYSE:HSY) reported an unexpected Q1 outperformance, with sales and profit ahead of prior expectations. Gum and mint products saw strong demand, linked to increased GLP-1 weight loss drug usage and related side effects. The company announced a zero-sugar Jolly Rancher iced tea line through a new collaboration with Ryl Tea. For investors tracking consumer staples, Hershey sits at the crossroads of snacking, refreshment, and health conscious choices. The Q1 performance highlights how...

Federal Home Loan Mortgage (FMCC) opened 2026 with Q1 results framed by trailing 12 month revenue of about US$22.0 billion and a loss, with basic EPS over that period at US$0.02 and net income excluding extra items at US$78 million in the red. Over recent quarters the company has seen quarterly revenue range from US$5.1 billion to US$6.2 billion, while basic EPS has moved between a profit of US$0.01 and a loss of roughly US$0.02. This has left investors focused on how much of that top line is...

Eli Lilly and Company reported past first-quarter 2026 results with sales of US$19.80 billion and net income of US$7.40 billion, sharply higher than a year earlier, driven largely by its incretin portfolio. The quarter also saw FDA approval and launch of Foundayo, Eli Lilly’s oral GLP‑1 weight-loss pill, alongside an FDA proposal to limit compounded GLP‑1 copies, which together could reshape the competitive landscape for its obesity and diabetes franchise. We’ll now examine how Eli Lilly’s...

If you are wondering whether Skyworks Solutions is attractively priced today, a key question is whether the current share price reflects the fundamentals or leaves room for mispricing. The stock last closed at US$69.40, with returns of 9.0% over 7 days, 30.4% over 30 days, 7.8% year to date, 9.6% over 1 year, and longer-term returns of a 26.2% decline over 3 years and a 54.5% decline over 5 years. These mixed returns sit against a backdrop of ongoing interest in semiconductor names and...

NextDecade (NEXT) shares were in focus after the company reported a wider first quarter 2026 net loss of US$136.41 million, along with detailed progress updates on its Rio Grande LNG project and future expansion plans. See our latest analysis for NextDecade. Despite the wider quarterly loss, investors have focused on construction progress and early LNG sales, with the share price up 10.44% over 7 days and a 48.02% 90 day share price return, while the 5 year total shareholder return is very...